Categories AlphaGraphs, Earnings, Health Care
MRK Earnings: Highlights of Merck’s Q1 2023 financial results
Pharma firm Merck & Co., Inc. (NYSE: MRK) on Thursday reported lower earnings for the first quarter of 2023, due to a sharp fall in revenues.
First-quarter sales decreased 9% year-over-year to $14.5 billion, hurt mainly by a double-digit fall in sales at the core pharmaceuticals division.
As a result, adjusted earnings dropped to $1.40 per share in the three-month period from $2.14 per share a year earlier. Unadjusted profit declined to $2.82 billion or $1.11 per share from $4.31 billion or $1.70 per share in the year-ago quarter.
Prior Performance
Most Popular
Important takeaways from Broadcom’s (AVGO) Q4 2023 earnings
Semiconductor company Broadcom, Inc. (NASDAQ: AVGO) ended fiscal 2023 on a positive note, delivering strong results for the fourth quarter. In the new fiscal year, the company’s focus will be
Here’s what Signet Jewelers (SIG) expects for the holiday season and beyond
Shares of Signet Jewelers Limited (NYSE: SIG) were down over 2% on Friday. The stock has gained 40% year-to-date and 27% over the past three months. The jewelry retailer saw
DOCU Earnings: DocuSign Q3 2024 revenue up 9%; profit beats estimates
eSignature service provider DocuSign, Inc. (NASDAQ: DOCU) reported higher revenues and better-than-expected adjusted earnings for the third quarter of 2024. The company also provided guidance for the fourth quarter and
